Uspharma Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Uspharma

Access the complete profile.

Uspharma Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	13900 Nw 57th Court Hialeah, FL 33014

Note: Revenues for privately held companies are statistical evaluations.


Uspharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Uspharma's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Uspharma is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Uspharma Annual Revenue and Growth Rate

Uspharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Uspharma's revenues are gauged from an analysis of company filings.

Uspharma's Income Statement (based on Industry Averages)

Uspharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Uspharma is developing and marketing. Uspharma doesn't have any recent trademark applications, indicating Uspharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
CANAPAS Topical analgesics, namely, creams, rubs, sprays, and patches, each of the foregoing containing not more than trace amounts of naturally occurring cannabidiol and having a delta-9 THC concentration of not more than 0.3% on a dry weight basis	12/20/2018
CANASIN Topical analgesics, namely, creams, rubs, sprays, and patches, each of the foregoing containing not more than trace amounts of naturally occurring cannabidiol and having a delta-9 THC concentration of not more than 0.3% on a dry weight basis	12/20/2018
CANGAY Topical analgesics, namely, creams, rubs, sprays, and patches, each of the foregoing containing not more than trace amounts of naturally occurring cannabidiol and having a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis	12/20/2018

See all trademarks and details in the Full Report.

Market Share of Uspharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Uspharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Uspharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
APOTEX/AVEVA DRUG DELIVERY SYSTEMS	Miramar, FL	100
NATURAL VITAMINS LABORATO	Opa Locka, FL	33
USPHARMA	Hialeah, FL	23
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	21
NUTRITION FORMULATORS	Miramar, FL	20
SMART TECH FLORIDA	Hollywood, FL	17

Future Competition: Uspharma's Fastest Growing Competitors

These companies are in the same general field as Uspharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)